Emergent Biosolutions Stock Performance
| EBS Stock | USD 5.02 0.16 3.09% |
Emergent Biosolutions holds a performance score of 10 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 4.89, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Emergent Biosolutions will likely underperform. Use Emergent Biosolutions jensen alpha, skewness, relative strength index, as well as the relationship between the value at risk and day median price , to analyze future returns on Emergent Biosolutions.
Risk-Adjusted Performance
10 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Emergent Biosolutions are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady fundamental drivers, Emergent Biosolutions unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (3.09) | Five Day Return (4.74) | Year To Date Return 93.82 | Ten Year Return (76.21) | All Time Return (57.09) |
1 | Disposition of 703 shares by Jennifer Fox of Emergent Biosolutions at 3. subject to Rule 16b-3 | 03/01/2024 |
2 | Emergent BioSolutions Posts Earnings Results, Beats Expectations By 0.14 EPS | 03/06/2024 |
3 | Acquisition by William Hartzel of 125000 shares of Emergent Biosolutions at 2.33 subject to Rule 16b-3 | 03/13/2024 |
4 | Assenagon Asset Management S.A. Buys 651,480 Shares of Emergent BioSolutions Inc. - MarketBeat | 04/05/2024 |
5 | Disposition of 585 shares by Coleen Glessner of Emergent Biosolutions at 2.29 subject to Rule 16b-3 | 04/24/2024 |
6 | Emergent Biosolutions Q1 2024 Earnings Preview | 04/30/2024 |
7 | Emergent BioSolutions announces reduction of about 300 employees | 05/01/2024 |
8 | Emergent BioSolutions gains as results top estimates, co to cut 300 jobs | 05/02/2024 |
9 | Is Emergent Biosolutions gaining more confidence from private investors | 05/06/2024 |
10 | Emergent BioSolutions to Hold Virtual Annual Meeting of Stockholders on Thursday, May 23, 2024 | 05/10/2024 |
11 | Disposition of 137 shares by Paul Williams of Emergent Biosolutions at 3. subject to Rule 16b-3 | 05/16/2024 |
12 | 7 Stocks to Buy Immediately Following Strong Earnings | 05/21/2024 |
| Begin Period Cash Flow | 576.3 M |
Emergent |
Emergent Biosolutions Relative Risk vs. Return Landscape
If you would invest 274.00 in Emergent Biosolutions on February 23, 2024 and sell it today you would earn a total of 228.00 from holding Emergent Biosolutions or generate 83.21% return on investment over 90 days. Emergent Biosolutions is generating 1.4486% of daily returns assuming volatility of 11.2247% on return distribution over 90 days investment horizon. In other words, 99% of stocks are less volatile than Emergent, and above 72% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Emergent Biosolutions Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Emergent Biosolutions' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Emergent Biosolutions, and traders can use it to determine the average amount a Emergent Biosolutions' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1291
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | EBS | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 11.22 actual daily | 96 96% of assets are less volatile |
Expected Return
| 1.45 actual daily | 28 72% of assets have higher returns |
Risk-Adjusted Return
| 0.13 actual daily | 10 90% of assets perform better |
Based on monthly moving average Emergent Biosolutions is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Emergent Biosolutions by adding it to a well-diversified portfolio.
Emergent Biosolutions Fundamentals Growth
Emergent Stock prices reflect investors' perceptions of the future prospects and financial health of Emergent Biosolutions, and Emergent Biosolutions fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Emergent Stock performance.
| Return On Equity | -0.61 | ||||
| Return On Asset | -0.0038 | ||||
| Profit Margin | (0.48) % | ||||
| Operating Margin | 0.13 % | ||||
| Current Valuation | 1.11 B | ||||
| Shares Outstanding | 52.4 M | ||||
| Price To Earning | 1.67 X | ||||
| Price To Book | 0.17 X | ||||
| Price To Sales | 0.10 X | ||||
| Revenue | 1.12 B | ||||
| Gross Profit | 290.1 M | ||||
| EBITDA | (34.4 M) | ||||
| Net Income | (223.8 M) | ||||
| Cash And Equivalents | 642.6 M | ||||
| Cash Per Share | 7.28 X | ||||
| Total Debt | 1.41 B | ||||
| Debt To Equity | 0.56 % | ||||
| Current Ratio | 3.92 X | ||||
| Book Value Per Share | 12.67 X | ||||
| Cash Flow From Operations | (34.1 M) | ||||
| Earnings Per Share | (10.97) X | ||||
| Market Capitalization | 263.06 M | ||||
| Total Asset | 3.17 B | ||||
| Retained Earnings | 734 M | ||||
| Working Capital | 28.2 M | ||||
| Current Asset | 537.41 M | ||||
| Current Liabilities | 99.61 M | ||||
About Emergent Biosolutions Performance
To evaluate Emergent Biosolutions Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Emergent Biosolutions generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Emergent Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Emergent Biosolutions market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Emergent's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 158.63 | 206.32 | |
| Return On Tangible Assets | (0.60) | (0.57) | |
| Return On Capital Employed | (0.15) | (0.14) | |
| Return On Assets | (0.41) | (0.39) | |
| Return On Equity | (1.17) | (1.11) |
Things to note about Emergent Biosolutions performance evaluation
Checking the ongoing alerts about Emergent Biosolutions for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Emergent Biosolutions help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Emergent Biosolutions is way too risky over 90 days horizon | |
| Emergent Biosolutions appears to be risky and price may revert if volatility continues | |
| The company reported the last year's revenue of 1.12 B. Reported Net Loss for the year was (223.8 M) with profit before taxes, overhead, and interest of 290.1 M. | |
| Emergent Biosolutions has about 642.6 M in cash with (34.1 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.28, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 70.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from investorplace.com: 7 Stocks to Buy Immediately Following Strong Earnings |
- Analyzing Emergent Biosolutions' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Emergent Biosolutions' stock is overvalued or undervalued compared to its peers.
- Examining Emergent Biosolutions' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Emergent Biosolutions' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Emergent Biosolutions' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Emergent Biosolutions' stock. These opinions can provide insight into Emergent Biosolutions' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Emergent Biosolutions. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. For more information on how to buy Emergent Stock please use our How to Invest in Emergent Biosolutions guide.Note that the Emergent Biosolutions information on this page should be used as a complementary analysis to other Emergent Biosolutions' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for Emergent Stock analysis
When running Emergent Biosolutions' price analysis, check to measure Emergent Biosolutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Emergent Biosolutions is operating at the current time. Most of Emergent Biosolutions' value examination focuses on studying past and present price action to predict the probability of Emergent Biosolutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Emergent Biosolutions' price. Additionally, you may evaluate how the addition of Emergent Biosolutions to your portfolios can decrease your overall portfolio volatility.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
Is Emergent Biosolutions' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Emergent Biosolutions. If investors know Emergent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Emergent Biosolutions listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.022 | Earnings Share (10.97) | Revenue Per Share 22.928 | Quarterly Revenue Growth 0.828 | Return On Assets (0) |
The market value of Emergent Biosolutions is measured differently than its book value, which is the value of Emergent that is recorded on the company's balance sheet. Investors also form their own opinion of Emergent Biosolutions' value that differs from its market value or its book value, called intrinsic value, which is Emergent Biosolutions' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Emergent Biosolutions' market value can be influenced by many factors that don't directly affect Emergent Biosolutions' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Emergent Biosolutions' value and its price as these two are different measures arrived at by different means. Investors typically determine if Emergent Biosolutions is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Emergent Biosolutions' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.